MedPath

FINLIUS

FINLIUS

Approved
DIN Number

02537257

Drug Class

Human

Market Date

Jul 2, 2024

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02537257
AIG Number0152506001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AC05 USTEKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

USTEKINUMABActive
Strength: 90 MG / 1 ML
Monograph: USTEKINUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.